Reduction of IGFBP1 in diabetes through both insulin-dependent and insulin-independent pathways is a novel mechanism by which carnosine contributes to the improvement of the metabolic control in diabetes [180]. The gene discussed is IGFBP1; the disease is diabetes mellitus.